Results 91 to 100 of about 61,813 (248)

Unveiling the Therapeutic Potential of Atractylis aristata Batt. Aqueous Extract: Anti‐inflammatory, Antioxidant, Antibacterial, Sedative Activities & Phytochemical Profiling

ChemistryOpen, EarlyView.
This study evaluates the pharmacological properties of the aqueous extract of Atractylis aristata, focusing on its antioxidant, anti‐inflammatory, antibacterial, and sedative activities. Phytochemical analysis identifies bioactive compounds, while in vitro and in vivo tests demonstrate its therapeutic potential in addressing oxidative stress ...
Asma Abid, Nourelhouda Mekhadmi, Randa Mlik, Assia Bentahar, Kamilia Bireche, Bariza Frih, Walid Boussebaa, Aicha Mouane, Nezar Cherrada, Ana Sanches Silva, Messaouda Dekmouche, Lazhar Bechki, Khalid Mashay Al‐Anazi, Mohammad Abul Farah, Ahmad Ali   +14 more
wiley   +1 more source

Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice

Libyan Journal of Medicine, 2020
The administration of therapeutic agents is difficult in many patients, such as patients with post-operative delirium or dementia or patients with schizophrenia, who are upset in an emergency room.
Hiroshi Ueno, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yu Takahashi, Yosuke Matsumoto, Motoi Okamoto, Takeshi Ishihara   +8 more
doaj   +1 more source

Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study

Neuropsychopharmacology Reports, 2019
Objective This Japanese, multicenter, randomized, double‐blind trial, evaluating the efficacy and safety of blonanserin compared with haloperidol in patients with schizophrenia, was previously published by Murasaki in the Japanese language.
Philip D. Harvey, Hiroshi Nakamura, Mitsukuni Murasaki   +2 more
doaj   +1 more source

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion

Saudi Pharmaceutical Journal, 2022
Purpose: The aim of this study was to design fast dissolving tablets (FDT) of the anti –psychiatric drug haloperidol in solid dispersion forms as a way to enhance its dissolution profile and anti-psychiatric effect.
Aya M. Eisa, Nagia A. El-Megrab, Hanan M. El-Nahas   +2 more
doaj  

Haloperidol Prophylaxis for Elderly Hip‐Surgery Patients at Risk for Delirium: A Randomized Placebo‐Controlled Study

Journal of The American Geriatrics Society, 2005
Objectives: To study the effectiveness of haloperidol prophylaxis on incidence, severity, and duration of postoperative delirium in elderly hip‐surgery patients at risk for delirium.
K. Kalisvaart, J. D. de Jonghe, Marja J. Bogaards, R. Vreeswijk, Toine Cornelis Gerardus Egberts, B. Burger, P. Eikelenboom, W. V. van Gool   +7 more
semanticscholar   +1 more source

Comparison of the incidence of recovery agitation with two different doses of ketamine in procedural sedation: A randomized clinical trial

Academic Emergency Medicine, EarlyView.
Abstract Objectives The objective was to compare the incidence of recovery agitation and efficacy of two different intravenous (IV) doses of ketamine (0.5 mg/kg vs. 1 mg/kg) in adult patients who presented to the emergency department (ED) requiring procedural sedation with ketamine.
Çağrı Türkücü, İsmet Parlak, Kamil Kokulu, Ekrem T. Sert, Hüseyin Mutlu   +4 more
wiley   +1 more source

Effects of Tandospirone, a 5-HT1A Agonistic Anxiolytic Agent, on Haloperidol-Induced Catalepsy and Forebrain Fos Expression in Mice

Journal of Pharmacological Sciences, 2009
We studied the effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. Haloperidol (0.5 mg/kg, i.p.) markedly increased the catalepsy time and enhanced Fos expression in the ...
Yukihiro Ohno, Saki Shimizu, Junta Imaki
doaj  

Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial

Archives of Academic Emergency Medicine, 2018
Introduction: About 5% of visits to emergency departments are made up of conversion disorder cases. This study was designed with the aim of comparing the effectiveness of quetiapine and haloperidol in controlling conversion disorder symptoms.
Saeed Reza Ghanbarizadeh, Hossein Dinpanah, Reza Ghasemi, Yaser Salahshour, Samaneh Sardashti, Mostafa Kamali, Seyed Reza Khatibi   +6 more
doaj   +1 more source

THE INVESTIGATION OF INFLUENCE OF GENETIC PROFILE ON THE EFFICACY AND SAFETY OF HALOPERIDOL IN PATIENTS WITH ALCOHOL DEPENDENCE

Архивъ внутренней медицины, 2016
In case of patients with alcohol addiction haloperidol is used to control the exacerbation of the addiction, but the empirical dose selection of haloperidol often results in adverse side effects.
M. S. Zastrozhin, E. A. Grishina, D. A. Sychev, L. M. Savchenko, E. A. Bryun, M. V. Prudnikova, O. M. Saraeva, V. V. Trofimov   +7 more
doaj   +1 more source

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.

New England Journal of Medicine, 2002
BACKGROUND Prevention of relapse is a major goal of maintenance treatment in patients with psychotic disorders. We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an older, conventional neuroleptic drug ...
J. Csernansky, Ramy A. Mahmoud, R. Brenner   +2 more
semanticscholar   +1 more source